Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Japan Pharma: Core Coverage Investment Thesis and Valuations (II/III)
Thematic (Sector/Industry)
356 Views
25 Sep 2018 11:43
Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Event-Driven
Philippines
South Korea
Sell / Short Ideas
India
Equity Bottom-Up
Asia Event-Driven
Asia ECM
Unpaywalled Insights
Trending Insights
More »
Nikkei 225 Index Rebalance Sep25: Performance of Potential Adds/Deletes & Positioning
Merger Arb Mondays (18 Aug) - Santos, Shibaura, ENN Energy, Kangji, OneConnect, Smart Share
Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
KOSPI Size Indices: Passive Flows for Many Active Changes
Japan Morning Connection: Markets Calm with No Further Tariffs for China
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Insight Stream
Japan Pharma: Core Coverage Investment Thesis and Valuations (II/III)
25 Sep 2018
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x